RE: Enhancing Capacity for Primary Care Research in Cancer Survivorship: National Cancer Institute Meeting Report

By sjmartinez • January 9, 2025

McClellan SP, Rivera-Avila DA, Cardenas E, Pérez-Zepeda MU, Dykens JA, Weine SM, Fitzgibbon M, Ganz P, García-Peña C. RE: Enhancing Capacity for Primary Care Research in Cancer Survivorship: National Cancer Institute Meeting Report. J Natl Cancer Inst. 2025 Jan 8:djae346. doi: 10.1093/jnci/djae346. Epub ahead of print. PMID: 39775888.

Tags: Hematology/Oncology, Publications

Adjuvant Osimertinib in Resected EGFR-Mutated Stage IB-IIIA Non-Small Cell Lung Cancer: Exploratory 8-year Overall Survival Landmark Update from the ADAURA Trial [161/175]

Wu YL, Majem M, John T, Grohé C, Wang J, Goldman JW, Lu S, Shepherd FA, Wang Q, Kato T, Aokage K, Zhong WZ, Laktionov[...]

Management Patterns and Outcomes for Relapsed or Refractory Hodgkin Lymphoma

Paniker AG, Marshalek JP, Chao E, Yashar D, Tomassetti S. Management Patterns and Outcomes for Relapsed or Refractory Hodgkin Lymphoma. J Hematol. 2026 Aug 31;15(4):188-197.[...]

Advancing clinical trials for rare renal cell carcinoma subtypes: Consensus statements from the International Kidney Cancer Symposium North America 2025 think tank

Msaouel P, La Rosa S, Abel EJ, Albiges L, Barata PC, Berg SA, Braun DA, Brugarolas J, Campbell MT, Carlo MI, Coleman K, Cost NG,[...]